Outlook Therapeutics (OTLK) news
Recent news
Outlook Therapeutics - Lawrence Kenyon to step down as CFO effective September 1, 226
AInvest Wire · 3d agoS&P AFMS rtgs on Santander Holdings USA; OTLK still stable
S&P Global Ratings has revised its outlook for Santander Holdings USA, Inc. to negative from stable, reflecting evolving credit risks associated with the institution’s capital structure and strategic direction amid broader economic uncertainties [1]. The rating agency emphasized that while the bank…
AInvest Wire · Aug 21, 2026S&P downgrades pretzel parent to 'B-'; OTLK stable
S&P Global Ratings has downgraded Pretzel Parent Inc.’s issuer credit rating to 'B-' from a previous level, citing evolving credit conditions and operational performance . The downgrade reflects a reassessment of the company’s financial stability and capacity to meet long-term obligations. Despite…
AInvest Wire · Aug 18, 2026Outlook Therapeutics prices $55M offering of stock and warranties
Outlook Therapeutics Inc. (NASDAQ: OTX) has announced the pricing of a public offering of 5.5 million shares of its common stock at a price of $10 per share, raising a total of $55 million [1]. The offering includes shares being sold by the company and warrants to purchase additional shares. The…
AInvest Wire · Aug 13, 2026Outlook Therapeutics to offer stock and warrants
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.